← Back to Clinical Trials
Recruiting NCT07811674

NCT07811674 Plantar Stimulation, Whole-Body Vibration, and Baduanjin for Muscle Activation

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07811674
Status Recruiting
Phase —
Sponsor Nanfang Hospital, Southern Medical University
Condition Flat Feet
Study Type INTERVENTIONAL
Enrollment 30 participants
Start Date 2026-09
Primary Completion 2027-05

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 25 Years
Study Type INTERVENTIONAL
Interventions
Whole-body Vibration Training,Whole-Body Vibration With Regional Plantar Stimulation,Baduanjin

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 30 participants in total. It began in 2026-09 with a primary completion date of 2027-05.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study will examine how different short-term exercise and vibration conditions affect lower-limb muscle activity in young adults with flat feet and young adults with normal feet. Participants will complete several conditions, including whole-body vibration, whole-body vibration combined with plantar stimulation under different areas of the foot, and a Baduanjin heel-raise exercise. Surface electromyography sensors will be placed on the skin over selected lower-limb muscles to record muscle activity before and during each condition. Each participant will complete all study conditions in a balanced order. This study does not aim to treat flat feet or evaluate long-term clinical benefits. The purpose is to collect preliminary information on immediate muscle activation and foot discomfort, which may help design future studies on foot-related exercise, plantar stimulation, and rehabilitation training.

Eligibility Criteria

Inclusion Criteria: 1. College students aged 18 to 25, regardless of gender 2. agree to participate in the study and voluntarily sign the informed consent form 3. and are deemed suitable to participate in this study by the researchers. Exclusion Criteria: 1. Persons with severe cardiovascular diseases, motor dysfunction or cognitive disorders 2. persons who have suffered severe trauma or been hospitalized recently and are unsuitable for exercise testing 3. persons with congenital lower limb or spinal deformities affecting foot posture other than flatfoot 4. persons with a medical history of muscular, neurological or skeletal system disorders affecting foot posture other than flatfoot 5. persons deemed ineligible to participate in this study by the investigators

Contact & Investigator

Central Contact

chao chen, PhD

✉ chenchao@smu.edu.cn

📞 +86-20-62787238

Principal Investigator

chao chen, PhD

PRINCIPAL INVESTIGATOR

Nanfang Hospital, Southern Medical University

Frequently Asked Questions

Who can join the NCT07811674 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 25 Years, studying Flat Feet. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07811674 currently recruiting?

Yes, NCT07811674 is actively recruiting participants. Contact the research team at chenchao@smu.edu.cn for enrollment information.

Where is the NCT07811674 trial being conducted?

This trial is being conducted at Guangzhou, China.

Who is sponsoring the NCT07811674 clinical trial?

NCT07811674 is sponsored by Nanfang Hospital, Southern Medical University. The principal investigator is chao chen, PhD at Nanfang Hospital, Southern Medical University. The trial plans to enroll 30 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology